Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases

Medicine and Dentistry

• Hispanic 100%
• Hepatocellular Carcinoma 61%
• Glycon 55%
• Odds Ratio 27%
• Incidence 27%
• Disparity 22%
• Maturity Onset Diabetes of the Young 22%
• Chronic Liver Disease 22%
• Race 22%
• Man 22%
• Cohort Analysis 11%
• Logistic Regression Analysis 5%
• Follow up 5%
• Insulin 5%
• Hemoglobin A1c 5%
• Patient with Type 2 Diabetes 5%
• Cardiovascular Disease 5%
• Thiazolidinedione 5%
• Nephropathy 5%
• Ethnic Disparity 5%
• Administration in Health System 5%
• Electronic Patient Record 5%
• Liver Cancer 5%
• Age 5%
• Veteran 5%
• Inpatient 5%
• Metformin 5%